Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · 2025
Surgical design and outcomes evaluation of two-jaw correction for short face syndrome with square jaw: A retrospective study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhou Zihang, Younis Hamza, Ge Han, Sun Xiaoshuang, Ye Bin, Li Jihua
Аннотация
Short face syndrome with square jaw presents with vertical facial deficiency and prominent mandibular angles, compromising facial proportions and aesthetics. This retrospective study evaluated a surgical strategy combining two-jaw orthognathic surgery and mandibular angle ostectomy, with autologous maxillary bone grafting using resected mandibular angles. Twenty patients diagnosed with short face syndrome and square jaw underwent simultaneous maxillary advancement, inferior repositioning, mandibular "V-line" osteotomy, and inlay maxillary grafting. Spiral CT scans were obtained preoperatively (T0), 1 month postoperatively (T1), and 1 year postoperatively (T2). Changes in facial height and angles were assessed using repeated measures ANOVA and Bonferroni-corrected pairwise comparisons. Statistically significant improvements were observed across all parameters from T0 to T1, with minimal relapse between T1 and T2. At T2, total facial height increased by 6.05 ± 0.38 mm (P < 0.001), and mandibular angle by 13.19 ± 1.11° (P < 0.001), while occlusal and mandibular plane angles also improved significantly. No major complications occurred, and patient satisfaction was high. This approach effectively restored vertical proportions and facial harmony, while maintaining long-term stability. The use of autologous grafts from the mandibular angle provides a reliable, integrated solution for managing bone gaps without secondary donor sites.